Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

498 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gilteritinib as treatment for extra-medullary relapse of FLT3-ITD acute myeloid leukemia FLT3-ITD, after allogeneic haematopoietic stem cell transplantation.
Iannotta R, Celentano M, Marotta S, Pedata CM, Riccardi C, Migliaccio I, Viola A, Muggianu SM, Falco C, Bovenzi D, Ferrara F, Picardi A. Iannotta R, et al. Among authors: viola a. Leuk Res Rep. 2022 Jul 27;18:100340. doi: 10.1016/j.lrr.2022.100340. eCollection 2022. Leuk Res Rep. 2022. PMID: 35958243 Free PMC article.
Myeloablative chemotherapy followed by autologous stem cell infusion may overcome the adverse prognostic impact of FLT3 (foetal liver tyrosine kinase 3) mutations in patients with acute myeloid leukaemia and normal karyotype.
Palmieri S, Ferrara F, Leoni F, Ciolli S, Pollio F, D'Amico MR, Celentano M, Viola A, Vicari L, Izzo B, Pane F. Palmieri S, et al. Among authors: viola a. Hematol Oncol. 2007 Mar;25(1):1-5. doi: 10.1002/hon.794. Hematol Oncol. 2007. PMID: 17036374
An antecedent diagnosis of refractory anemia with excess blasts has no influence on mobilization of peripheral blood stem cells and hematopoietic recovery after autologous stem cell transplantation in acute myeloid leukemia.
Viola A, Falco C, D'Elia R, D'Amico MR, Vicari L, Tambaro FP, Correale P, Laudati D, Palmieri S, Ferrara F. Viola A, et al. Eur J Haematol. 2007 Jan;78(1):41-7. doi: 10.1111/j.1600-0609.2006.00777.x. Epub 2006 Oct 17. Eur J Haematol. 2007. PMID: 17042770
Vinorelbine plus intermediate dose cyclophosphamide is an effective and safe regimen for the mobilization of peripheral blood stem cells in patients with multiple myeloma.
Annunziata M, Celentano M, Pocali B, D'Amico MR, Palmieri S, Viola A, Copia C, Falco C, Del Vecchio L, Ferrara F. Annunziata M, et al. Among authors: viola a. Ann Hematol. 2006 Jun;85(6):394-9. doi: 10.1007/s00277-005-0058-0. Epub 2006 Mar 15. Ann Hematol. 2006. PMID: 16538502 Clinical Trial.
HFE gene mutations in patients with acute leukemia.
Viola A, Pagano L, Laudati D, D'Elia R, D'Amico MR, Ammirabile M, Palmieri S, Prossomariti L, Ferrara F. Viola A, et al. Leuk Lymphoma. 2006 Nov;47(11):2331-4. doi: 10.1080/10428190600821898. Leuk Lymphoma. 2006. PMID: 17107905
Favorable outcome in patients with acute myelogenous leukemia with the nucleophosmin gene mutation autografted after conditioning with high-dose continuous infusion of idarubicin and busulfan.
Ferrara F, Izzo T, Criscuolo C, Riccardi C, Muccioli G, Viola A, Pane F, Palmieri S. Ferrara F, et al. Among authors: viola a. Biol Blood Marrow Transplant. 2010 Jul;16(7):1018-24. doi: 10.1016/j.bbmt.2010.02.011. Epub 2010 Feb 19. Biol Blood Marrow Transplant. 2010. PMID: 20172040 Free article.
498 results